Capillary Hemangioma
The most common orbital and eyelid tumor of childhood — a benign 'strawberry' vascular birthmark that usually fades on its own but can threaten vision when it blocks or presses on the eye.
Medically reviewed by Mark S. Brown, MDOculoplastic SurgeonLast updated June 2026
Part of our complete guide to Orbital Tumors — this page covers capillary hemangioma in depth.
What Is a Capillary Hemangioma?
A capillary hemangioma (also called an infantile or “strawberry” hemangioma) is a benign tumor of rapidly growing blood-vessel cells — and the most common orbital and periorbital tumor of childhood. It appears in the first weeks of life as a raised, red or bluish, spongy lesion; about 60% occur on the head and neck. The upper eyelid is involved more often than the lower, and lesions deep in the orbit can push the eye forward (proptosis). It is more common in girls and in low-birth-weight infants.
Natural History: Growth, Then Fading
The pattern is predictable: rapid growth for roughly the first 6–12 months (the lesion may darken and swell with crying), then a plateau, then slow spontaneous shrinkage (involution) beginning around age one. About 60% have resolved by age 5 and 90–95% by age 9. Because most disappear on their own, many hemangiomas are simply observed — unless vision is at risk.
When Vision Is at Risk
An infant’s visual system is still wiring itself to the brain; anything that degrades the image in one eye can cause amblyopia (permanent “lazy eye”). An eyelid or orbital hemangioma can do this three ways:
- Occlusion — the lesion physically covers the pupil
- Induced astigmatism — pressure on the globe distorts its shape and blurs the image
- Strabismus — orbital mass effect misaligns the eyes
Every periocular hemangioma therefore needs ophthalmic monitoring during the growth phase, even when no treatment is planned. Multiple lesions occasionally warrant systemic evaluation (rarely, visceral involvement or Kasabach–Merritt syndrome).
Treatment
The photographs below follow a single eyelid hemangioma treated with topical timolol over 14 months:
Hemangioma Response to Timolol Over Time
Drag the control to follow one infant's capillary hemangioma shrinking over 14 months of topical timolol.
Drag the slider to follow one infant's capillary hemangioma over 14 months of topical timolol — before treatment, then 1, 2, 4, 6, 9, 12, and 14 months.
- Observation — appropriate for most lesions that do not threaten vision, given reliable involution.
- Oral propranolol — the modern first-line treatment for vision-threatening lesions; this beta-blocker usually shrinks proliferating hemangiomas in most cases under pediatric supervision (with monitoring for bradycardia, low blood pressure, and low blood sugar) and has largely replaced systemic steroids.
- Topical timolol — for small, superficial lesions.
- Steroid injection or surgical excision — for selected localized lesions, or to remove residual fibrofatty tissue after involution.
- Amblyopia management — patching and refractive correction alongside any lesion-directed treatment.
Management is shared between the pediatrician, a pediatric ophthalmologist, and an oculoplastic surgeon — the surgeon’s role is monitoring orbital involvement and operating when the lesion or its remnant requires excision.
Adult with a similar diagnosis on a scan? The cavernous hemangioma is a different condition despite the similar name — an adult orbital lesion that does not fade on its own. See our comparison of the two.
Capillary hemangioma is also covered in our guide to congenital eyelid and orbital conditions.
Frequently Asked Questions
- Will my baby's hemangioma go away on its own?
- Usually, yes. Capillary hemangiomas typically grow rapidly for the first 6–12 months, then slowly shrink (involute) — about 60% are gone by age 5 and 90–95% by age 9. Treatment is recommended only when the lesion threatens vision, blocks the pupil, presses on the eye, or causes significant deformity.
- How can a hemangioma affect my child's vision?
- Three main ways: by physically blocking the visual axis (occlusion), by pressing on the eye and changing its shape (inducing astigmatism), or by causing misalignment (strabismus). Each of these can lead to amblyopia — permanently reduced vision in the developing eye — which is why eyelid and orbital hemangiomas need ophthalmic monitoring even when no treatment is planned.
- What is the treatment for a vision-threatening hemangioma?
- Oral propranolol (a beta-blocker) is the first-line treatment and has largely replaced steroids — it reliably shrinks proliferating hemangiomas under pediatric supervision. Alternatives include topical timolol for small superficial lesions, steroid injection, and surgical excision for selected well-defined lesions or residual tissue after involution.
Ready to discuss Capillary Hemangioma?
Schedule a consultation with Mark S. Brown, MD to learn if this procedure is right for you.